GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $4.71 $5.41 Friday, 19th Apr 2024 AUPH stock ended at $4.99. This is 3.74% more than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 4.92% from a day low at $4.78 to a day high of $5.01.
90 days $4.71 $8.49
52 weeks $4.71 $12.42

Historical Aurinia Pharmaceuticals Inc prices

Date Open High Low Close Volume
2023-08-09 $9.71 $9.73 $9.36 $9.46 1 375 593
2023-08-08 $9.67 $9.99 $9.58 $9.71 1 608 214
2023-08-07 $9.81 $10.05 $9.46 $9.75 2 491 860
2023-08-04 $10.59 $10.83 $9.79 $9.82 4 736 700
2023-08-03 $10.40 $11.15 $10.09 $10.56 8 491 849
2023-08-02 $10.23 $10.44 $9.91 $10.13 3 720 896
2023-08-01 $11.47 $11.51 $10.44 $10.45 4 476 898
2023-07-31 $12.38 $12.38 $11.50 $11.58 3 810 278
2023-07-28 $11.14 $12.42 $11.13 $12.27 4 271 396
2023-07-27 $11.09 $11.10 $10.91 $11.07 1 765 637
2023-07-26 $10.65 $11.47 $10.60 $11.09 2 786 954
2023-07-25 $10.79 $10.82 $10.57 $10.65 1 803 825
2023-07-24 $10.95 $10.97 $10.66 $10.87 1 790 757
2023-07-21 $11.28 $11.28 $10.90 $10.94 2 374 391
2023-07-20 $11.29 $11.33 $11.06 $11.21 1 688 322
2023-07-19 $11.50 $11.59 $11.08 $11.33 2 289 212
2023-07-18 $11.30 $11.66 $11.30 $11.48 1 666 414
2023-07-17 $11.19 $11.72 $11.15 $11.25 2 173 762
2023-07-14 $11.08 $11.21 $10.74 $11.12 1 464 237
2023-07-13 $11.19 $11.26 $10.93 $10.99 1 725 982
2023-07-12 $11.69 $11.73 $11.07 $11.10 2 269 721
2023-07-11 $10.84 $11.49 $10.59 $11.40 3 040 161
2023-07-10 $10.29 $10.87 $10.15 $10.73 2 546 684
2023-07-07 $10.18 $10.31 $10.00 $10.29 2 059 011
2023-07-06 $9.76 $10.35 $9.75 $10.12 2 819 131
Click to get the best stock tips daily for free!

About Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.... AUPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT